Artio Medical Closes Tranche of $12 Million in Series A Financing
Artio Medical Closes Tranche of $12 Million in Series A Financing Company to accelerate clinical testing and prepare for commercialization of its broad portfolio of products News provided by Share this article Share this article PRAIRIE VILLAGE, Kan., April 29, 2021 /PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today the closing of an additional $12 million tranche of Series A financing, bringing the total to $46 million. Led by existing investors Nathaniel and Sa...